University of Geneva

U. Of Texas Research Branch Maintains Hectic Partnering Pace The increasingly busy University of Texas MD Anderson Cancer Center inked three new alliances with biopharmaceutical companies in the pas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Gilead Pays Goldfinch $55m U

When people talk about personalized medicine, they usually talk about stratification, the use of biomarkers to identify a subset of patients expected to respond to a specific therapeutic agent. But a

IN VITRO DIAGNOSTICS Mergers & Acquisitions Abingdon Health Ltd. Molecular Vision Ltd. Abingdon Health Ltd. has purchased a 50.1% equity stake in fellow private diagnostics firm Molecular Vision